Comment on CEO defends raising price of drug from $13.50 a pill to $750: 'We have to turn a profit'

CEO defends raising price of drug from $13.50 a pill to $750: 'We have to turn a profit'

A former hedge fund manager is justifying his startup company's decision to increase the price of a life-saving drug from $13.50 per pill to $750 by saying it's necessary in order to create better medicine in the future. Martin Shkreli's Turing Pharmaceuticals acquired the drug Daraprim in August, The Guardian reports, which is used to treat toxoplasmosis, an infection that can be fatal when it affects babies born to infected mothers and people with compromised immune systems due to AIDS and certain cancers.

 

Comment On This Story

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More News